Switzerland’s Sandoz files antitrust lawsuit against Amgen in US
By Thomson ReutersApr 14, 2025 | 12:12 AM
(Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept).
(Reporting by Abinaya Vijayaraghavan; Editing by Rashmi Aich)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
